FundedIQ

Funded Startups in Guangdong

Snapmaker’s $147M Series C on 2026-07-08 stands out as the only disclosed round in the $100M+ range; the other four listings (lecarc, Dezhi Matrix, LEITZ I…

Snapmaker’s $147M Series C on 2026-07-08 stands out as the only disclosed round in the $100M+ range; the other four listings (lecarc, Dezhi Matrix, LEITZ Intelligent, RabPharma) show undisclosed amounts. The disclosed amount profile is therefore concentrated in a single visible outlier, with the remainder lacking disclosed figures across the 2025-09-12 to 2026-08-11 window.

All five entries are tied to Guangdong, China, spanning 2025 (3 rounds) and 2026 (2 rounds). Sector tags are all distinct across the list (Industrial/Product Design/Semiconductor for lecarc; 3D/Hardware/Manufacturing for Snapmaker; AI/Electronics/Semiconductors for Dezhi Matrix; Energy for LEITZ Intelligent; Biotechnology/Pharmaceuticals for RabPharma), and the stage mix is mostly Series A (4 of 5), with Snapmaker as the only Series C (2026-07-08).

Most recent rounds

5 shown
L
lecarc
Guangdong, China · Industrial, Product Design, Semiconductor
Series A · Aug 2026
Undisclosed
S
Snapmaker
Guangdong, China · 3D, Hardware, Manufacturing
Series C · Jul 2026
$147M
D
Dezhi Matrix
Guangdong, China · Artificial Intelligence, Electronics, Semiconductors
Series A · Nov 2025
Undisclosed
L
LEITZ Intelligent
Guangdong, China · Energy
Series A · Sep 2025
Undisclosed
R
RabPharma
Guangdong, China · Biotechnology, Pharmaceuticals
Series A · Sep 2025
Undisclosed

Related listings

Frequently asked

What does the largest disclosed round look like in this Guangdong set, and is it followed by other large disclosed checks?

Snapmaker’s $147M on 2026-07-08 is the only disclosed round and also the only one above $100M; every other entry in the five-row list (lecarc, Dezhi Matrix, LEITZ Intelligent, RabPharma) is undisclosed.

How concentrated are the deals temporally among the most recent entries?

The displayed rounds run from 2025-09-12 (RabPharma, Series A) to 2026-08-11 (lecarc, Series A), with 3 entries in 2025 and 2 in 2026. That means the most recent five-row snapshot is split across two calendar years rather than clustering into a single month range.

Is there any city-level concentration beyond Guangdong itself, or is the geography uniform?

Geography is uniform at the city level in this view: all five companies are listed under Guangdong, China. There are no other city names appearing in the set, so no intra-city concentration signals are visible.

What stage mix dominates, and where does the one non-Series-A deal fall?

Series A dominates with 4 of 5 entries: lecarc (2026-08-11), Dezhi Matrix (2025-11-26), LEITZ Intelligent (2025-09-20), and RabPharma (2025-09-12). Snapmaker is the sole Series C (2026-07-08), and it is also the only disclosed amount ($147M).

Are there sector outliers, or is the sector labeling broad across the list?

Sector labeling is broad with no repeated sector tags: each company’s sector set is distinct. The clearest outlier is Snapmaker’s 3D/Hardware/Manufacturing (2026-07-08, $147M), while the others span Industrial/Product Design/Semiconductor (lecarc), AI/Electronics/Semiconductors (Dezhi Matrix), Energy (LEITZ Intelligent), and Biotechnology/Pharmaceuticals (RabPharma).

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.